$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000139681414000003 Filed on February 25, 2014

Income Statement

Concept	2013 Q4	2013	2012 Q4
Revenue	$33.56M	$85.55M	$10.45M
YoY Change	221.19%	118.89%	148.81%
Cost Of Revenue	$18.38M	$54.77M	$9.672M
YoY Change	89.99%	70.42%	46.55%
Gross Profit	$15.19M	$30.78M	$778.0K
YoY Change	1852.19%	343.18%	-132.42%
Gross Profit Margin	45.25%	35.98%	7.44%
Selling, General & Admin	$20.20M	$62.51M	$13.40M
YoY Change	50.75%	34.99%	86.11%
% of Gross Profit	133.0%	203.09%	1722.37%
Research & Development	$4.800M	$21.56M	$3.200M
YoY Change	50.0%	116.97%	52.38%
% of Gross Profit	31.6%	70.05%	411.31%
Depreciation & Amortization	$1.700M	$5.747M	$1.450M
YoY Change	17.24%	1.75%	13.28%
% of Gross Profit	11.19%	18.67%	186.38%
Operating Expenses	$43.38M	$138.8M	$26.28M
YoY Change	65.09%	57.09%	179.56%
Operating Profit	-$28.20M	-$53.29M	-$25.50M
YoY Change	10.57%	8.1%	116.11%
Interest Expense	-$1.900M	$7.253M	-$300.0K
YoY Change	533.33%	301.38%	-50.0%
% of Operating Profit
Other Income/Expense, Net	-$300.0K	-$11.06M	-$200.0K
YoY Change	50.0%	270.83%
Pretax Income	-$12.00M	-$64.35M	-$16.30M
YoY Change	-26.38%	23.09%	6.54%
Income Tax	$0.00	-$442.0K	$0.00
% Of Pretax Income
Net Earnings	-$11.96M	-$63.91M	-$16.35M
YoY Change	-26.86%	22.24%	6.84%
Net Earnings / Revenue	-35.62%	-74.7%	-156.42%
Basic Earnings Per Share	-$0.36	-$1.93
Diluted Earnings Per Share	-$0.36	-$1.93	-$500.0K
COMMON SHARES
Basic Shares Outstanding	33.54M shares	33.18M shares	32.55M shares
Diluted Shares Outstanding		33.18M shares

Balance Sheet

Concept	2013 Q4	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.20M	$72.20M	$41.10M
YoY Change	75.67%	75.67%	-46.06%
Cash & Equivalents	$12.52M	$12.50M	$12.52M
Short-Term Investments	$59.60M	$59.60M	$30.90M
Other Short-Term Assets	$4.400M	$4.400M	$3.400M
YoY Change	29.41%	29.41%	9.68%
Inventory	$15.56M	$15.60M	$12.08M
Prepaid Expenses
Receivables	$14.59M	$14.60M	$4.352M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$106.8M	$106.8M	$60.92M
YoY Change	75.23%	75.37%	-26.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.18M	$48.20M	$39.12M
YoY Change	23.18%	23.27%	55.82%
Goodwill	$10.33M		$8.297M
YoY Change	24.48%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.402M	$3.400M	$511.0K
YoY Change	565.75%	580.0%	6.68%
Total Long-Term Assets	$63.07M	$63.00M	$51.13M
YoY Change	23.35%	23.05%	65.79%
TOTAL ASSETS
Total Short-Term Assets	$106.8M	$106.8M	$60.92M
Total Long-Term Assets	$63.07M	$63.00M	$51.13M
Total Assets	$169.8M	$169.8M	$112.1M
YoY Change	51.55%	51.47%	-1.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.069M	$3.100M	$2.569M
YoY Change	19.46%	19.23%	-25.32%
Accrued Expenses	$17.89M	$16.60M	$9.792M
YoY Change	82.65%	69.39%	36.78%
Deferred Revenue
YoY Change
Short-Term Debt	$99.00M	$99.00M	$0.00
YoY Change
Long-Term Debt Due	$120.0M	$1.000M	$0.00
YoY Change		25.0%	-100.0%
Total Short-Term Liabilities	$121.9M	$121.9M	$14.16M
YoY Change	761.42%	758.45%	-55.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$200.0K	$25.19M
YoY Change	-100.0%	-99.23%	35.9%
Other Long-Term Liabilities	$3.190M	$6.400M	$2.275M
YoY Change	40.22%	6.67%	-18.11%
Total Long-Term Liabilities	$3.190M	$6.600M	$27.47M
YoY Change	-88.39%	-79.38%	28.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$121.9M	$121.9M	$14.16M
Total Long-Term Liabilities	$3.190M	$6.600M	$27.47M
Total Liabilities	$128.6M	$128.6M	$46.20M
YoY Change	178.3%	178.35%	-29.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$296.4M		-$232.5M
YoY Change	27.49%		29.01%
Common Stock	$34.00K		$33.00K
YoY Change	3.03%		32.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00		$2.000K
YoY Change	-100.0%		0.0%
Treasury Stock Shares	0.000 shares		1.065K shares
Shareholders Equity	$41.25M	$41.20M	$65.86M
YoY Change
Total Liabilities & Shareholders Equity	$169.8M	$169.8M	$112.1M
YoY Change	51.55%	51.47%	-1.27%

Cashflow Statement

Concept	2013 Q4	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$11.96M	-$63.91M	-$16.35M
YoY Change	-26.86%	22.24%	6.84%
Depreciation, Depletion And Amortization	$1.700M	$5.747M	$1.450M
YoY Change	17.24%	1.75%	13.28%
Cash From Operating Activities	-$6.900M	-$43.84M	-$21.18M
YoY Change	-67.42%	-37.49%	178.68%
INVESTING ACTIVITIES
Capital Expenditures	-$2.800M	$12.17M	-$4.730M
YoY Change	-40.8%	-33.33%	89.96%
Acquisitions
YoY Change
Other Investing Activities	$18.02M	-$30.77M	$27.09M
YoY Change	-33.48%	173.03%	-391.6%
Cash From Investing Activities	$15.22M	-$42.94M	$22.36M
YoY Change	-31.93%	45.46%	-290.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	820.0K	89.17M	240.0K
YoY Change	241.67%	40.18%	-99.51%
NET CHANGE
Cash From Operating Activities	-6.900M	-43.84M	-21.18M
Cash From Investing Activities	15.22M	-42.94M	22.36M
Cash From Financing Activities	820.0K	89.17M	240.0K
Net Change In Cash	9.140M	2.390M	1.420M
YoY Change	543.66%	-106.63%	-95.23%
FREE CASH FLOW
Cash From Operating Activities	-$6.900M	-$43.84M	-$21.18M
Capital Expenditures	-$2.800M	$12.17M	-$4.730M
Free Cash Flow	-$4.100M	-$56.01M	-$16.45M
YoY Change	-75.08%	-36.63%	221.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2569000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3069000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4352000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14590000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17885000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9792000	USD
CY2013Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1526000	USD
CY2012Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	360000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12576000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11603000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	337639000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	298317000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	23956000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2493000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4776000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11513000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2493000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11513000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4776000	USD
CY2011	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1644000	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3959000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	831000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3376000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1437000	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1287000	shares
CY2012Q4	us-gaap	Assets Assets	112054000	USD
CY2013Q4	us-gaap	Assets Assets	169820000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	60922000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	106751000	USD
CY2013Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	59632000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30897000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10126000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12515000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26133000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46168000	USD
CY2012Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	10.97
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	162885	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	58354	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	490464	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32624049	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33636442	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32622984	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33636442	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43313000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63931000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52269000	USD
CY2011	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	6000	USD
CY2012	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2013	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2013Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	98961000	USD
CY2012Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	54772000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	31744000	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15310000	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	32139000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	54772000	USD
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	16739000	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	18376000	USD
CY2012Q4	us-gaap	Cost Of Revenue CostOfRevenue	9672000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	11391000	USD
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	6685000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	10214000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	14791000	USD
CY2012Q1	us-gaap	Cost Of Revenue CostOfRevenue	6495000	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	9287000	USD
CY2013	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	0	USD
CY2012	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	395000	USD
CY2011	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	1429000	USD
CY2011	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	51222000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2012	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2309000	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	21039000	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10100000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2300000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1300000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1008000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3720000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3212000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1897000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1707000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	129993000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	103954000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89150000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	114819000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3374000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1997000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3891000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3248000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3631000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5149000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3388000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1696000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	103954000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	121486000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8507000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	0	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2013	us-gaap	Depreciation Depreciation	3700000	USD
CY2011	us-gaap	Depreciation Depreciation	2000000	USD
CY2012	us-gaap	Depreciation Depreciation	3600000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5747000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4314000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5648000	USD
CY2013	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the Financial Accounting Standards Board, or FASB, issued a new accounting standard which will require the presentation of certain unrecognized tax benefits as reductions to deferred tax assets rather than as liabilities in the consolidated balance sheets when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The new standard requires adoption on a prospective basis in the first quarter of 2015; however, early adoption is permitted. The Company does not anticipate that this adoption will have a significant impact on its financial position, results of operations, or cash flows.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.72
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.64
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.93
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.50
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0069
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3827
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4291
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3962
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0211
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0084
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0212
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0479
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0673
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0398
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0013
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0169
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0000
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1635000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5488000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11792000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13843000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	81000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	322000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	754000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1157000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3208000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-32000	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-273000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3398000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1062000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	10328000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	8297000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	0	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2011	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3019000	USD
CY2012	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43328000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52281000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64351000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-442000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10244000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2549000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1386000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2239000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10238000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	922000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-400000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-400000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16778000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1065000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-472000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-360000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3480000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10832000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1047000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-106000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	27000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	59000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	972000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	608000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-14000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	110000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	224000	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	800000	USD
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2000000	USD
CY2013	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000	USD
CY2011	us-gaap	Interest Expense InterestExpense	4780000	USD
CY2012	us-gaap	Interest Expense InterestExpense	1807000	USD
CY2013	us-gaap	Interest Expense InterestExpense	7253000	USD
CY2012	us-gaap	Interest Paid InterestPaid	4229000	USD
CY2013	us-gaap	Interest Paid InterestPaid	3500000	USD
CY2011	us-gaap	Interest Paid InterestPaid	4739000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3946000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2017000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	15557000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	12077000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5290000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4081000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6321000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5979000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	255000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	259000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	275000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	46199000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	128571000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112054000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	169820000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	121943000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14156000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	25191000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	98961000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25191000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2389000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	20035000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-36042000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	87158000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	89165000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	63610000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29522000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-36123000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-43560000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-70130000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-43216000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31000000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-43328000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-63909000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-52281000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-16346000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-15745000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-14031000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-11956000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-14784000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-11894000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-23138000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-8296000	USD
CY2013Q4	us-gaap	Net Rentable Area NetRentableArea	106000	sqft
CY2011Q3	us-gaap	Net Rentable Area NetRentableArea	13000	sqft
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11062000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4227000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2983000	USD
CY2013	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2007Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	3300000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	138840000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	54790000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	88382000	USD
CY2013Q4	us-gaap	Operating Expenses OperatingExpenses	43384000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	30232000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	18970000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	18941000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	29151000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	36073000	USD
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	26279000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	24192000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-49298000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-53289000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-39101000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	33679000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4765000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5017000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5072000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5130000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4978000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8717000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4700000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4800000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4900000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3402000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	15000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-22000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-22000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	15000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-22000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2275000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3190000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	71000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111000	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7191000	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1365000	USD
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2011	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	907000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6167000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12794000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18257000	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	52619000	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	114299000	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	54047000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2819000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1920000	USD
CY2012	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2011	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	120000000	USD
CY2011	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	38016000	USD
CY2012	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2013	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62855000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49006000	USD
CY2012Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62900000	USD
CY2011	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	27500000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	53120000	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	22649000	USD
CY2013	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	85564000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	870000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3856000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	136000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60758000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50719000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48182000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39116000	USD
CY2013	us-gaap	Repayments Of Debt RepaymentsOfDebt	27500000	USD
CY2012	us-gaap	Repayments Of Debt RepaymentsOfDebt	26250000	USD
CY2011	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9937000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21560000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14873000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1633000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1523000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-296429000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-232520000	USD
CY2011	us-gaap	Revenues Revenues	15689000	USD
CY2012	us-gaap	Revenues Revenues	39084000	USD
CY2013	us-gaap	Revenues Revenues	85551000	USD
CY2012Q2	us-gaap	Revenues Revenues	12344000	USD
CY2013Q3	us-gaap	Revenues Revenues	23259000	USD
CY2013Q2	us-gaap	Revenues Revenues	17141000	USD
CY2013Q4	us-gaap	Revenues Revenues	33564000	USD
CY2013Q1	us-gaap	Revenues Revenues	11587000	USD
CY2012Q1	us-gaap	Revenues Revenues	7804000	USD
CY2012Q4	us-gaap	Revenues Revenues	10450000	USD
CY2012Q3	us-gaap	Revenues Revenues	8486000	USD
CY2011	us-gaap	Royalty Expense RoyaltyExpense	-227000	USD
CY2013	us-gaap	Royalty Expense RoyaltyExpense	623000	USD
CY2012	us-gaap	Royalty Expense RoyaltyExpense	278000	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	2623000	USD
CY2011	us-gaap	Royalty Revenue RoyaltyRevenue	3720000	USD
CY2012	us-gaap	Royalty Revenue RoyaltyRevenue	2503000	USD
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6895000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	81956000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	18191000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20159000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62508000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46306000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	4776000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2493000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	11513000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5204537	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	166222	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	5038315	shares
CY2013Q4	us-gaap	Share Price SharePrice	57.49
CY2012Q2	us-gaap	Share Price SharePrice	9.75
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	59637000	USD
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	30924000	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37109000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	770000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	135000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3856000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	65855000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	41249000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	48269000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-48383000	USD
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	420000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	1354000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, the valuation of assets acquired, impairment of long-lived assets, goodwill, stock-based compensation and valuation of deferred tax assets. The Company's critical accounting policies are those that are both most important to the Company's consolidated financial condition and results of operations and require the most difficult, subjective, or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17500000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	20700000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16600000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33181895	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16437464	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30331965	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33182000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16437000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30332000	shares
CY2013Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1625000	USD
CY2012Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1873000	USD
CY2013Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	8001000	USD
CY2012Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	5686000	USD
CY2013	pcrx	Ageof Children Pediatric Patientsto Study Exparel AgeofChildrenPediatricPatientstoStudyEXPAREL	P2Y
CY2011	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-85000	USD
CY2013	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	459000	USD
CY2012	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-239000	USD
CY2013	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	100000	USD
CY2012	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	400000	USD
CY2011	pcrx	Amortization Of Unfavorable Lease Accrual AmortizationOfUnfavorableLeaseAccrual	400000	USD
CY2013	pcrx	Amount Received In Lockbox Restricted For Payment Of Royalty Interest AmountReceivedInLockboxRestrictedForPaymentOfRoyaltyInterest	2500000.0	USD
CY2013Q4	pcrx	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	13000	USD
CY2012Q4	pcrx	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	28000	USD
CY2013Q4	pcrx	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	8000	USD
CY2012Q4	pcrx	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1000	USD
CY2013	pcrx	Beginning Period Prior To Product Expiration Allowed For Returning Product BeginningPeriodPriorToProductExpirationAllowedForReturningProduct	P6M
CY2013Q4	pcrx	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.73
CY2012Q4	pcrx	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.79
CY2013	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	0	USD
CY2011	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	0	USD
CY2013	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	972000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2012	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	18390000	USD
CY2011	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	5074000	USD
CY2013	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	2800000.0	shares
CY2013Q4	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	158000000	USD
CY2012	pcrx	Debt Issuance On Issuance Of Warrants Value DebtIssuanceOnIssuanceOfWarrantsValue	1354000	USD
CY2013Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	121486000	USD
CY2012Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	103954000	USD
CY2012	pcrx	Equity Componentof Convertible Debt EquityComponentofConvertibleDebt	0	USD
CY2013	pcrx	Equity Componentof Convertible Debt EquityComponentofConvertibleDebt	24936000	USD
CY2011	pcrx	Equity Componentof Convertible Debt EquityComponentofConvertibleDebt	0	USD
CY2013Q4	pcrx	Goodwill Recorded For Earn Out Payments GoodwillRecordedForEarnOutPayments	2031000	USD
CY2012Q4	pcrx	Goodwill Recorded For Earn Out Payments GoodwillRecordedForEarnOutPayments	339000	USD
CY2012	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	1076000	USD
CY2013	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	434000	USD
CY2011	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	1815000	USD
CY2012Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	26871000	USD
CY2013Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	100207000	USD
CY2013Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	0	USD
CY2012Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	27500000	USD
CY2012Q2	pcrx	Management Agreement Contract Sum ManagementAgreementContractSum	7700000	USD
CY2013	pcrx	Maximum Ageof Pediatric Patientsto Study Exparel MaximumAgeofPediatricPatientstoStudyEXPAREL	P18Y
CY2012Q4	pcrx	Milestone Paymentto Skyepharma Netof Contingent Consideration Liability MilestonePaymenttoSkyepharmaNetofContingentConsiderationLiability	7958000	USD
CY2013	pcrx	Minimum Ageof Pediatric Patientsto Study Exparel MinimumAgeofPediatricPatientstoStudyEXPAREL	P12Y
CY2013	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.5
CY2012	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	customer
CY2013	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2013	pcrx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
CY2013	pcrx	Percentage Of Royalty On Sale Of Product PercentageOfRoyaltyOnSaleOfProduct	0.03
CY2013Q4	pcrx	Operating Loss Carryforwards Related To Stock Based Compensation OperatingLossCarryforwardsRelatedToStockBasedCompensation	6500000	USD
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2012	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	10339000	USD
CY2013	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	2031000	USD
CY2011	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2013	pcrx	Payment Period Of Royalty Interest From Restricted Amount In Lockbox PaymentPeriodOfRoyaltyInterestFromRestrictedAmountInLockbox	P12M
CY2013	pcrx	Period After Product Expiration Upto Which Product Is Allowed To Be Returned PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned	P12M
CY2013	pcrx	Period Within Which Cumulative Percentage Of Change In Ownership Occurs As Condition To Offset Taxable Income Or Tax PeriodWithinWhichCumulativePercentageOfChangeInOwnershipOccursAsConditionToOffsetTaxableIncomeOrTax	P3Y
CY2013Q1	pcrx	Proceeds From Sale Of Unused Net Operating Losses ProceedsFromSaleOfUnusedNetOperatingLosses	400000	USD
CY2013Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	1245000	USD
CY2012Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	238000	USD
CY2013Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1246000	USD
CY2012Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1680000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	823000	USD
CY2013Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	1020000	USD
CY2013Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	226000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	857000	USD
CY2012Q2	pcrx	Stock Issued During Period Shares Follow On Public Offering Issues StockIssuedDuringPeriodSharesFollowOnPublicOfferingIssues	6900000	shares
CY2013	pcrx	Stock Issued During Period Shares Treasury Stock Reissuedfor Exerciseof Stock Options StockIssuedDuringPeriodSharesTreasuryStockReissuedforExerciseofStockOptions	1065	shares
CY2011	pcrx	Stock Issued During Period Value Follow On Public Offering Issues StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues	49006000	USD
CY2012	pcrx	Stock Issued During Period Value Follow On Public Offering Issues StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues	62855000	USD
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2012	pcrx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	100000	USD
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33714015	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	606371440	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0001396814-14-000003-index-headers.html	Edgar Link	pending
0001396814-14-000003-index.html	Edgar Link	pending
0001396814-14-000003.txt	Edgar Link	pending
0001396814-14-000003-xbrl.zip	Edgar Link	pending
exhibit1046.htm	Edgar Link	pending
exhibit1047.htm	Edgar Link	pending
exhibit1048.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
pcrx-12312013x10k.htm	Edgar Link	pending
pcrx-12312013xex311.htm	Edgar Link	pending
pcrx-12312013xex312.htm	Edgar Link	pending
pcrx-12312013xex321.htm	Edgar Link	pending
pcrx-12312013xex322.htm	Edgar Link	pending
pcrx-20131231.xml	Edgar Link	completed
pcrx-20131231.xsd	Edgar Link	pending
pcrx-20131231_cal.xml	Edgar Link	unprocessable
pcrx-20131231_def.xml	Edgar Link	unprocessable
pcrx-20131231_lab.xml	Edgar Link	unprocessable
pcrx-20131231_pre.xml	Edgar Link	unprocessable
performancegraph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2013 Q4 Form 10-K Financial Statement

#000139681414000003 Filed on February 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2013 Q4 Form 10-K Financial Statement

#000139681414000003 Filed on February 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx